#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Crigler-Najjar syndrome Langerhans' cell histiocytosis Congenital megacolon Pouchitis MELAS syndrome Huntington's disease Hereditary spastic paraplegia Necrotising myositis Extra-osseous Ewing's sarcoma metastatic Cortical dysplasia Biliary neoplasm Factor VIII deficiency Glycogen storage disease type I Dent's disease Congenital growth hormone deficiency More trials…

    Learn about Rare Diseases

    Rosai-Dorfman syndrome – Life with Disease Hairy cell leukaemia – Treatment Aicardi-Goutieres syndrome – Trials in Disease IgA nephropathy – Basic Information Synovial sarcoma Antisynthetase syndrome – Basic Information Familial amyotrophic lateral sclerosis – Trials in Disease Prader-Willi syndrome – Life with Disease Haemophilia B with anti factor IX – Basic Information Cerebral arteriovenous malformation haemorrhagic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lysine Acetate Air, Medicinal PAPAVERINE HYDROCHLORIDE Hdp-101 Amiloride Hydrochloride Mebufotenin Paracetamol Ph. Eur. Protease Hydrochlorothiazide Clomipramine Hydrochloride Atomoxetine Siponimod Indocyanine Green Efzofitimod Cefazolin Sodium Tub-040 Opelconazole Kbp-336 Pentosan Polysulfate Sodium Cytisinicline More therapies…

    Learn about Your Condition

    Sickle cell anaemia Gaucher's disease type III Fatty acid oxidation disorder Fontan procedure Peripheral artery angioplasty Meningioma Biliary tract operation Abdominal infection Colon cancer Supraventricular tachycardia Adenomatous polyposis coli Arterial tortuosity syndrome Generalised anxiety disorder Cutaneous sarcoidosis Transitional cell carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Krankenhaus Nordwest GmbH

Krankenhaus Nordwest GmbH

Steinbacher Hohl 2-26, Praunheim, Frankfurt, 60488, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Futibatinib with Pembrolizumab and Chemotherapy for Patients with Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Futibatinib
    • Irinotecan Hydrochloride Trihydrate
    • Cisplatin
    France Germany Spain

  • Study for Patients with Metastatic Colorectal Cancer with BRAF V600E Mutation Using Encorafenib, Cetuximab, and Chemotherapy Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Encorafenib
    • Irinotecan Hydrochloride Trihydrate
    • Bevacizumab
    Belgium Bulgaria Czechia Denmark Finland Germany +7

  • Study on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer stage II
    • Rectal cancer stage II
    Investigated Drugs:
    • Capecitabine
    Austria Germany

  • Study Comparing Sacituzumab Govitecan with Standard Treatment for Patients with Metastatic Colorectal Cancer

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bevacizumab
    • Regorafenib
    • Tipiracil
    Germany

  • Study on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Vinorelbine
    • Atezolizumab
    • Cisplatin
    France Germany Hungary Italy The Netherlands Poland +3

  • Study on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Biliary cancer metastatic
    • Biliary neoplasm
    Investigated Drugs:
    • Tegafur
    • Glucose
    • Capecitabine
    Belgium Denmark France Germany Italy Norway +2

  • Study on Regorafenib and Nivolumab for Patients with Advanced Gastro-Oesophageal Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Nivolumab
    • Regorafenib
    Austria Germany Italy Spain

  • Study of Sacituzumab Govitecan for Patients with Advanced Esophagogastric Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Sacituzumab Govitecan
    Austria Germany

  • Study on BI 907828 for Patients with Advanced Biliary Tract, Pancreatic, Lung, or Bladder Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Bladder cancer
    • Lung adenocarcinoma
    Investigated Drugs:
    • (3S,3’S,3A’s,10A’s)-6-Chloro-3′-(3-Chloro-2-Fluorophenyl)-1′-(Cyclopropylmethyl)-6′-Methyl-2-Oxo-1,2,3′,3A’,10′,10A’-Hexahydro-1’H-Spiro[Indole-3,2′-Pyrrolo[2′,3′:4,5]Pyrrolo[1,2-B]Indazole]-7′-Carboxylic Acid
    Austria Belgium France Germany Spain

  • Study of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma urethra
    • Transitional cell cancer of the renal pelvis and ureter
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Enfortumab Vedotin
    Belgium Czechia Denmark France Germany Hungary +4
Previous Page
1 … 10 11 12 13 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!